Ikena Oncology, Inc. Soared

Ikena Oncology, Inc. (IKNA:NASDAQ) rocketted at $17.16, a gain of 1152.6%. On Tue, Aug 05, 2025, IKNA:NASDAQ hit a New 2-Week Intraday Low of $1.36. The stock got featured on our News Catalysts scanner on Tue, Aug 05, 2025 at 11:51 AM in the 'MISCELLANEOUS' category. From Tue, Jul 22, 2025, the stock recorded 20.00% Up Days and 90.91% Green Days
The share price of the company has been moving sideways in recent weeks.
About Ikena Oncology, Inc. (IKNA:NASDAQ)
Ikena Oncology Inc is an oncology company. It is focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.
Top 10 Gainers:
- Ikena Oncology, Inc. (IKNA:NASDAQ), 1152.55%
- Y-mAbs Therapeutics, Inc. (YMAB:NASDAQ), 103.34%
- Visionary Holdings Inc. (GV:NASDAQ), 89.81%
- SolarMax Technology, Inc. (SMXT:NASDAQ), 78.49%
- Ameresco, Inc. (AMRC:NYSE), 48.98%
- STAAR Surgical Company (STAA:NASDAQ), 46.13%
- Xometry, Inc. (XMTR:NASDAQ), 42.98%
- Ontrak, Inc. (OTRK:NASDAQ), 40.06%
- Zepp Health Corporation (ZEPP:NYSE), 38.12%
- Arteris, Inc. (AIP:NASDAQ), 37.57%